Legal, state-licensed cannabis businesses paid an estimated $2.24 billion in excess federal taxes in 2025 - costs generated entirely by a 1980s tax code provision that bars them from deducting ordinary business expenses. The illicit market, which the provision was originally designed to punish, paid none of it. A refreshed analysis from Whitney Economics puts hard numbers on a structural disadvantage that has now cost the legal industry roughly $15 billion since 2018.
A Tax Code Built for Drug Traffickers Now Targets Licensed Retailers
Section 280E of the Internal Revenue Code was written to deny business deductions to drug traffickers. The logic was punitive and intentional: if you cannot deduct your costs, your effective tax burden becomes crushing. Four decades later, that same provision applies to dispensary operators who hold state licenses, post compliance bonds, submit to seed-to-sale tracking in systems like METRC, maintain compliant packaging standards, fund security infrastructure, and file every required tax return. The illicit operator down the street does none of that - and files nothing.
What 280E means in practice is that a licensed retail dispensary cannot deduct labor costs, rent, legal and accounting fees, marketing spend, point-of-sale system subscriptions, security services, or most other standard operating expenses on its federal return. Only the cost of goods sold - the direct cost of acquiring cannabis inventory - is deductible. Every other line item that a liquor store, a pharmacy, or a hardware retailer would write off without a second thought becomes taxable income for a cannabis operator. The result is an effective federal tax rate that can exceed 70% for retail-heavy businesses, according to the Whitney Economics figures. No other legal American industry operates under anything close to those conditions.
"The amount of additional taxes cannabis operators pay is staggering," said Beau Whitney, Chief Economist at Whitney Economics. "In 2025, there was an estimated $2.24 billion in excess cannabis-related federal taxes due to the IRS's 280E tax policy. The industry is being taxed out of business."
The Competitive Math Is Not Subtle
Here is the thing about a 70% effective tax rate: it does not just compress margins. It distorts the entire competitive structure of the market. A licensed dispensary pricing a gram of flower has to absorb 280E exposure into every SKU. An unlicensed seller has no such constraint. The illicit operator does not carry compliance costs, testing fees, excise tax, or a state license renewal bill - and now, thanks to 280E, the legal operator is also carrying a federal tax load that would be unrecognizable in any other industry. The price gap between regulated and unregulated product does not exist because legal operators are inefficient. It exists because policy manufactured it.
Multi-state operators and vertically integrated companies sometimes have more room to structure around 280E - allocating more costs to the cost-of-goods-sold category through their cultivation and manufacturing operations - but single-location retail dispensaries rarely have that flexibility. For the independent storefront operator, 280E hits at its worst, with the fewest structural options to absorb it. That is not an accident of business size. It is the geometry of a provision that treats every cannabis sale as a criminal enterprise regardless of licensure.
Would Rescheduling Change the Calculation?
The prevailing argument is that moving cannabis to Schedule III would sever its connection to 280E, since the code targets Schedule I and II substances. If that interpretation holds, operators could deduct ordinary business expenses for the first time - labor, rent, professional services, software, security, marketing. Cash flow improves materially. Lender conversations get easier. Valuations that have been artificially suppressed by tax liability start to reflect actual business performance.
That sounds tidy on paper, but the picture is more complicated. The IRS has not issued formal guidance confirming that 280E would no longer apply to rescheduled cannabis businesses. Tax attorneys have flagged the possibility that the agency could take a narrower position - or that prior-year tax liabilities accrued under 280E would remain enforceable regardless of any schedule change. Operators carrying significant back exposure should not assume rescheduling wipes the slate.
Rescheduling is also not full federal legalization. It does not open interstate commerce. It does not resolve the banking access problem that pushes cash-heavy dispensaries toward costly workarounds and elevated security risk. It does not automatically fix cashless payment infrastructure, which remains a patchwork of workarounds - cashless ATM systems, PIN debit arrangements - precisely because financial institutions remain wary of federal exposure. The broader structural constraints on the licensed cannabis business do not dissolve with a schedule change.
What does not change regardless of the rescheduling timeline: $2.24 billion left the legal industry last year. Fifteen billion dollars over seven years. Those are not projections or estimates of future harm. They are documented costs already absorbed by businesses that chose to operate inside the law - and they compound every quarter the policy stands unchanged.
What Operators Can Do While Policy Catches Up
Working with a cannabis-specialized CPA or tax attorney is not optional at this point - it is a baseline operational requirement. The distinction between deductible cost of goods sold and non-deductible operating expenses is technical and contested enough that operators without proper guidance routinely leave money on the table or, worse, take positions that draw IRS scrutiny. Inventory accounting methodology matters. How a vertically integrated operator allocates costs across cultivation, processing, and retail matters. None of this eliminates 280E exposure, but it can reduce the damage at the margins.
Beyond tax structuring, the $2.24 billion figure is itself a policy argument - one with an unusually clean narrative. Regulators and legislators who want to support the legal market over the illicit one have a straightforward case here: the current federal tax structure actively subsidizes unlicensed competition. That is not a talking point. It is arithmetic. Industry associations, trade groups, and licensed operators who engage in advocacy work now have a fresh, well-sourced number to put in front of lawmakers. Whether Congress moves on 280E through rescheduling, standalone legislation, or broader cannabis reform, the economic case for change has rarely been this clearly documented.
The illicit market did not grow because licensed operators failed to build good businesses. It persists, in significant part, because federal policy prices compliance at a premium no other legal industry is asked to pay.
